Loading ETF profile…
This fund primarily allocates capital to equity investments, specifically common and preferred shares, across companies of all market capitalizations. Under typical market conditions, at least 80% of its net assets, along with any borrowed capital used for investment, will be directed toward firms predominantly active in the healthcare industry. These healthcare companies are defined as those primarily involved in the research, development, production, or distribution of healthcare-related products and services. The portfolio maintains a non-diversified investment approach.
| Symbol | Name | Weight | Market Value |
|---|---|---|---|
| LLY | ELI LILLY & CO | 21.53% | $9.01M |
| — | ASCENDIS PHARMA A/S | 14.45% | $6.04M |
| GILD | GILEAD SCIENCES INC | 4.62% | $1.93M |
| LEGN | LEGEND BIOTECH CORP-ADR | 4.46% | $1.87M |
| RYTM | RHYTHM PHARMACEUTICALS INC | 4.38% | $1.83M |
| ABBV | ABBVIE INC | 3.34% | $1.40M |
| ISRG | INTUITIVE SURGICAL INC | 3.19% | $1.34M |
| INSM | INSMED INC | 2.90% | $1.21M |
| RVMD | REVOLUTION MEDICINES INC | 2.73% | $1.14M |
| NTRA | NATERA INC | 2.71% | $1.13M |
| BSX | BOSTON SCIENTIFIC CORP | 2.70% | $1.13M |
| MRK | MERCK & CO. INC. | 2.40% | $1.00M |
| DHR | DANAHER CORP | 2.19% | $916.80K |
| PCVX | VAXCYTE INC | 2.12% | $887.08K |
| ABVX | ABIVAX SA-ADR | 2.05% | $856.25K |
| ABC | CENCORA INC | 1.92% | $805.17K |
| GH | GUARDANT HEALTH INC | 1.87% | $781.32K |
| ARGX | ARGENX SE - ADR | 1.87% | $780.72K |
| UNH | UNITEDHEALTH GROUP INC | 1.78% | $742.82K |
| VRTX | VERTEX PHARMACEUTICALS INC | 1.74% | $728.17K |
| PODD | INSULET CORP | 1.71% | $716.40K |
| IDXX | IDEXX LABORATORIES INC | 1.63% | $683.31K |
| PTCT | PTC THERAPEUTICS INC | 1.37% | $571.68K |
| NVO | NOVO-NORDISK A/S-SPONS ADR | 1.23% | $514.64K |
| ADPT | ADAPTIVE BIOTECHNOLOGIES | 1.17% | $489.21K |